HMGB1 and Sepsis: Using a lipopolysaccharide (LPS) sepsis model in rats, we demonstrate that danaparoid sodium (50 U/kg) can reduce pulmonary histopathology, decrease mortality, and diminish inflammatory mediators and high mobility group box 1 (HMGB1) serum and lung levels.